Nathaniel J. Myall, M., Jennifer G. Whisenant, P., Joel W. Neal, M., Wade T. Iams, M., Karen L. Reckamp, M., Sally York, M., . . . Sukhmani K. Padda, M. Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors. Elsevier.
Chicago Style (17th ed.) CitationNathaniel J. Myall, MD, et al. Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors. Elsevier.
MLA (9th ed.) CitationNathaniel J. Myall, MD, et al. Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors. Elsevier.
Warning: These citations may not always be 100% accurate.